Patents by Inventor Marc Pedemonte

Marc Pedemonte has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cyclic depsipeptide as chemotherapeutic anticancer agent
    Publication number: 20050239694
    Abstract: Serratamolide, also named cyclo[(3R)-3-hydroxydecanoyl-L-seryl-(3R)-3-hydroxydecanoyl-L-seryl], is a cyclic depsipeptide isolated from cultures of bacteria of the species Serratia marcescens. Serratamolide decreases the viability of, and induces apoptosis in several cancer cells (leukemias, myelomas, carcinomas, etc.), virtually with no effect on non-cancer cells. This makes serratamolide, and its pharmaceutically acceptable addition salts and/or solvates, useful as anticancer chemotherapeutic agent, particularly against leukemia, lymphoma, myeloma, carcinoma, melanoma and sarcoma.
    Type: Application
    Filed: April 1, 2005
    Publication date: October 27, 2005
    Inventors: Ricardo Tomas, Beatriz Ramoneda, Ernest Lledo, Marc Pedemonte, Marta Casas